CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - EUR (€) € in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Research and development services	€ 35	€ 111
Grants	633	542
Total revenues	668	653
Expenses
Research and development	1,055	970
General and administrative	1,187	1,064
Total expenses	2,284	2,076
Operating loss	(1,616)	(1,423)
Interest expense	2,708	2,674
Other (income) expense	(149)	110
Loss before income tax provision	(4,133)	(4,165)
Income tax provision	(25)	(22)
Net loss	(4,158)	(4,187)
Other Comprehensive Loss
Foreign currency translation adjustment	4	12
Comprehensive loss	€ (4,154)	€ (4,175)
Basic and diluted loss per share	€ (0.01)	€ (0.01)
Weighted average number of shares used in per share calculations	303,757,622	303,757,622